Skip to content

Outcomes of Total Arterial Coronary Artery Bypass Grafting

Multicentric Registry Database of Total Arterial CABG

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03231527
Acronym
MOZART
Enrollment
0
Registered
2017-07-27
Start date
2017-02-01
Completion date
2018-12-31
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Surgical Wound Infection

Brief summary

real-life retrospective multicentric database for the analysis of the long term outcomes of total arterial CABG in comparison to saphenous vein based CABG

Detailed description

This aim of this registry is to create a multi centric database for the analysis of basic long term outcomes and immediate postoperative outcomes of total arterial CABG in comparison to saphenous vein based CABG. The registry will include both on pump and off pump surgery. The registry is intended to capture the real-life picture of the CABG scenario among centers worldwide

Interventions

myocardial revascularization

Sponsors

Campus Bio-Medico University
CollaboratorOTHER
Universitaire Ziekenhuizen KU Leuven
CollaboratorOTHER
Thorax Centrum Twente
CollaboratorOTHER
Golden Jubilee National Hospital
CollaboratorOTHER_GOV
University of Glasgow
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* elective CABG patients (on pump or off pump surgery; pedicles of skletonized internal mammary artery harvesting technique; open or endoscopic vein harvesting technique)

Exclusion criteria

* urgent or emergent CABG * concomitant procedures * redo cases

Design outcomes

Primary

MeasureTime frameDescription
Survivaldata collection every year up to 5 years after operation/entry in the registryLong term survival
MACCEsdata collection every year up to 5 years after operation/entry in the registryMajor cardiac events (myocardial infarction, stroke, readmission for CHF)
target vessel revascularizationdata collection every year up to 5 years after operation/entry in the registryreadmission for revascularization due to graft failure
Wound infectiondata collection every year up to 5 years after operation/entry in the registryReadmission for wound infection (superficial sternal wound infection, deep sternal wound infection, saphenous vein related wound infection, need for VAC therapy, need for surgical debridment, need for prolonged antibiotic therapy)

Secondary

MeasureTime frameDescription
Duration of ventilationperioperative (in hospital)number of hours ventilated
Cardiac complicationperioperative (in hospital)prolonged inotropic support (more than 48 hrs), IABP, ECMO
Blood product usageperioperative (in hospital)unit of concentrated red cells, fresh frozen plasma, platelets
Renal complicationsperioperative (in hospital)acute kidney injury not requiring dyalisis, dialysis
GI complicationsperioperative (in hospital)mesenteric ischemia requiring surgery, ileus
Respiratory complicationsperioperative (in hospital)pneumonia, reintubation, pneumothorax requiring drainage, effusion requiring drainage
Bleedingperioperative (in hospital)surgical bleeding requiring re-exploration
Length of ICU stayperioperative (in hospital)number of days in ICU
Length of hospital stayperioperative (in hospital)number of days in hospital

Countries

Belgium, Italy, Netherlands, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026